Drug disposal study: where does MK-5475 go?
NCT ID NCT06777602
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 1 study gave a single IV dose of radiolabeled MK-5475 to 8 healthy men to see how the drug is absorbed, broken down, and removed from the body. Researchers measured levels in blood, urine, and feces over time. The study does not test treatment for any disease and offers no direct health benefit to participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Labcorp Clinical Research Unit Inc. (Site 0001)
Madison, Wisconsin, 53704, United States